Compare GT & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GT | BCRX |
|---|---|---|
| Founded | 1898 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2005 | 1995 |
| Metric | GT | BCRX |
|---|---|---|
| Price | $6.93 | $9.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | $10.56 | ★ $20.82 |
| AVG Volume (30 Days) | ★ 7.7M | 5.9M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | N/A | ★ 1.21 |
| Revenue | ★ $18,280,000,000.00 | $25,186,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.06 | $12.55 |
| P/E Ratio | ★ N/A | $8.07 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.14 | $6.00 |
| 52 Week High | $12.03 | $11.31 |
| Indicator | GT | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.02 | 64.12 |
| Support Level | $6.64 | $7.99 |
| Resistance Level | $7.33 | $10.32 |
| Average True Range (ATR) | 0.25 | 0.50 |
| MACD | 0.15 | -0.04 |
| Stochastic Oscillator | 76.21 | 63.64 |
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific. The majority of its revenue is generated from the Americas business, which develops, manufactures, distributes, and sells tires and related products and services in North, Central, and South America, along with selling tires to various export markets, mainly through intersegment sales.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.